Brief: JPMorgan's Long Position In H-Shares Of Cansino Biologics Falls To 6.93% - HKEX Filing
Dec 15 (Reuters) - Hong Kong stock exchange filing:
* JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF CANSINO
BIOLOGICS 6185.HK REDUCED TO 6.93% ON DEC 9 FROM 7.45% - HKEX
FILING
Source text
Further company coverage: 6185.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025